CNS Drugs : Impact Factor & More
eISSN: 1179-1934pISSN: 1172-7047
Share this on:
Key Metrics
CiteScore 
9.8
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Neurology (clinical)
SNIP
1.87
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on CNS Drugs
CNS Drugs Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in CNS Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in CNS Drugs
Opioid Use Disorder Treatment Gaps and Emerging Therapeutics to Address Them.
- 19 May 2026
- CNS drugs
Enhancing Drug Response Prediction in Epilepsy with Emerging Multimodal Models: Focus on Clinical, Pharmacologic, and Genomic Factors.
- 16 May 2026
- CNS drugs
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review.
- 16 May 2026
- CNS drugs
Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes".
- 14 May 2026
- CNS drugs
Authors' Reply to Damkier: Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta Analysis of Congenital Malformations and Prenatal Outcomes".
- 14 May 2026
- CNS drugs
Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes.
- 14 May 2026
- CNS drugs
Opioid Use Disorder Treatment Gaps and Emerging Therapeutics to Address Them.
- 19 May 2026
- CNS drugs
Enhancing Drug Response Prediction in Epilepsy with Emerging Multimodal Models: Focus on Clinical, Pharmacologic, and Genomic Factors.
- 16 May 2026
- CNS drugs
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review.
- 16 May 2026
- CNS drugs
Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes".
- 14 May 2026
- CNS drugs
Authors' Reply to Damkier: Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta Analysis of Congenital Malformations and Prenatal Outcomes".
- 14 May 2026
- CNS drugs
Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes.
- 14 May 2026
- CNS drugs
FAQs on CNS Drugs
How long has CNS Drugs been actively publishing? 
What is the publishing frequency of CNS Drugs?
How many articles did CNS Drugs publish last year?
What is the eISSN & pISSN for CNS Drugs?
What is Citescore for CNS Drugs?
What is SNIP score for CNS Drugs?
What is the SJR for CNS Drugs?
Who is the publisher of CNS Drugs?
